Colon cancer, the second leading cause of cancer deaths in the United States, has predominately been tested through a colonoscopy. But detecting colon cancer could become much easier and less invasive in the near future with doctors at John Hopkins announcing that they have found a way to screen for colon cancer through a blood test. This may be a sigh of relief for many, with doctors recommending that every person over the age of 50 recieve a colonoscopy.

By analyzing the blood test results of patients with colon cancer compared to those without the disease, the researchers have been able to distinguish the results of those who have the cancer from those who do not. In their initial tests, John Hopkins researchers have been able to determine and identify pre-cancerous polyps, cancer related proteins, and cells produced by cancers as effectively as a colonoscopy. If the testing passes the next stage of the FDA approval process–expanding the testing to 500 people to confirm their findings–the blood tests could be available to the general public in as little as two years time. Researchers say that the procedure will be most effective at determining who should get a colonoscopy and who should not. Eventually, the doctors believe that a blood test could go as far as determining who has colon cancer.

The blood testing method will appeal to those who find a colonoscopy too intrusive or uncomfortable, hopefully ensuring that more people will be tested for the cancer. With the number of people over the age of 50 growing each year and the risk of developing colon cancer increasing as you age, increased testing means saved lives. These new findings are just one more reason why performing preventative health screens is a smart and easy way to ensure your future health.

HealthCheckUSA currently offers a colon cancer screening blood  test known as the fecal occult blood test, or FOBT. This colon cancer screening is recommended annually for men and women after age 50, and even earlier for people who may be at high risk for colon cancer. If you have any questions about ordering a colon cancer screening, or any other lab test, please contact us.

Increased levels of Homocysteine above 14 µmol/ have been shown to double the risk for onset of Alzheimer’s. Good news is that elevated levels of homocysteine can be reversed. These results add AD to the list of risks associated with high homocysteine levels, which have also been linked to heart disease and stroke. Since homocysteine levels are related to plasma levels of vitamins-folic acid, B6, and B12-related to homocysteine levels, elevated homocysteine levels can effectively be reversed with vitamin supplementation or ore agressively with a script such as Metanx.

National HIV Testing Day (NHTD) is an annual event run by the National Association of People with AIDS encouraging at-risk or high-risk people to take voluntary HIV testing. The National Association of People with AIDS distributes Aids testing day supplies to local communities to help facilitate NHTD. In fact, community leaders can simply go online to order copies of the kit and download campaign materials to adapt and use. This is the 10th year of National HIV Testing Day.

The organizer of NHTD is the National Association of People with AIDS. NAPWA is the oldest coalition of people living with HIV/AIDS in the world and the oldest U.S. national AIDS organization.